SANOFI CONSUMER HEALTHCARE INDIA
|
SANOFI CONSUMER HEALTHCARE INDIA Last 5 Year Cashflow Statement History
[Standalone]
Dec2024 | Dec2023 | |
---|---|---|
Profit Before Tax | ₹247 Cr | ₹219 Cr |
Adjustment | ₹0.50 Cr | ₹-2.20 Cr |
Changes In working Capital | ₹316 Cr | ₹-213 Cr |
Cash Flow after changes in Working Capital | ₹563 Cr | ₹3.80 Cr |
Cash Flow from Operating Activities | ₹439 Cr | ₹-0.40 Cr |
Cash Flow from Investing Activities | ₹1.90 Cr | - |
Cash Flow from Financing Activities | ₹-116 Cr | ₹2.00 Cr |
Net Cash Inflow / Outflow | ₹325 Cr | ₹1.60 Cr |
Opening Cash & Cash Equivalents | ₹1.60 Cr | - |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - |
Effect of Foreign Exchange Fluctuations | - | - |
Closing Cash & Cash Equivalent | ₹327 Cr | ₹1.60 Cr |
Compare Cashflow Statement of peers of SANOFI CONSUMER HEALTHCARE INDIA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SANOFI CONSUMER HEALTHCARE INDIA | ₹11,703.6 Cr | -1.1% | 2.4% | NA | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,267.0 Cr | 0.7% | 2.8% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,672.0 Cr | -0.8% | 3.7% | 48.6% | Stock Analytics | |
CIPLA | ₹119,713.0 Cr | -0.2% | -0.1% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,195.0 Cr | 3.4% | 11.2% | 17.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,999.0 Cr | 0.6% | -5.2% | -4.9% | Stock Analytics |
SANOFI CONSUMER HEALTHCARE INDIA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SANOFI CONSUMER HEALTHCARE INDIA | -1.1% |
2.4% |
|
SENSEX | -0.9% |
0.4% |
1.4% |
You may also like the below Video Courses